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Background: Nasopharyngeal carcinoma (NPC) has a high metastatic feature. N,N0-Dinitrosopiperazine (DNP) is
involved in NPC metastasis, but its mechanism is not clear. The aim of this study is to reveal the pathogenesis of
DNP-involved metastasis. 6-10B cells with low metastasis are from NPC cell line SUNE-1, were used to investigate
the mechanism of DNP-mediated NPC metastasis.
Results: 6-10B cells were grown in DMEM containing 2H4-L-lysine and
13C6
15N4-L-arginine or conventional L-lysine
and L-arginine, and identified the incorporation of amino acid by matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry. Labeled 6-10B cells were treated with DNP at 0 -18 μM to establish the
non-cytotoxic concentration (NCC) range. NCC was 0 -10 μM. Following treatment with DNP at this range, the
motility and invasion of cells were detected in vitro, and DNP-mediated metastasis was confirmed in the nude
mice. DNP increased 6-10B cell metastasis in vitro and vivo. DNP-induced protein expression was investigated using
a quantitative proteomic. The SILAC-based approach quantified 2698 proteins, 371 of which showed significant
change after DNP treatment (172 up-regulated and 199 down-regulated proteins). DNP induced the change in
abundance of mitochondrial proteins, mediated the status of oxidative stress and the imbalance of redox state,
increased cytoskeletal protein, cathepsin, anterior gradient-2, and clusterin expression. DNP also increased the
expression of secretory AKR1B10, cathepsin B and clusterin 6-10B cells. Gene Ontology and Ingenuity Pathway
analysis showed that DNP may regulate protein synthesis, cellular movement, lipid metabolism, molecular transport,
cellular growth and proliferation signaling pathways.
Conclusion: DNP may regulate cytoskeletal protein, cathepsin, anterior gradient-2, and clusterin expression,
increase NPC cells motility and invasion, is involved NPC metastasis.
Keywords: Dinitrosopiperazine, Carcinogen, Nasopharyngeal carcinoma, Metastasis, Quantitative proteomicsBackground
Nasopharyngeal carcinoma (NPC) is a common malignant
cancer in southern China [1]. Epidemiological investiga-
tions have revealed that the incidence of NPC has
remained high in endemic regions, particularly in south-
ern China with an incidence of 30–80 per 100,000 people* Correspondence: tangfaqing33@hotmail.com
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reproduction in any medium, provided the orper year [2]. NPC has the feature of high invasion and
metastasis, and cervical lymphadenopathy is often the
only clinical manifestation at initial diagnosis of NPC
patients [3]. Therapeutic failure in advanced NPC has
resulted from both high rates of local recurrence and dis-
tant metastasis.
In Chinese populations in high-incidence regions, the
relative risk of NPC is related to their eating habits of the
region, particularly with dietary intake of salt-preserved fish
[2,4-6]. The process of salt preservation is inefficient and
foods can become partially putrefied , consequently, these
foods accumulate significant levels of nitrosamines [7,8],his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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perazine (DNP) is a predominant volatile nitrosamine in
salted fish [11,12]. The carcinogenic potential of DNP in
salt-preserved fish is supported by experiments in rats,
which develop malignant nasal and NPC [13-15]. Further-
more, DNP can induce malignant transformation of
human embryonic nasopharyngeal epithelial cells [16]. Our
previous works have shown that DNP induces rat NPC
and shows organ specificity for nasopharyngeal epithelium,
and found that DNP triggers over-expression of hot shock
protein 70 and mucin 5B [17]. Additionally, DNP induces
ezrin phosphorylation at Thr567 through activating Rho
kinase and protein kinase C, and increases motility and in-
vasion of NPC cells [18]. In the present study, to fully
understand the mechanism of DNP-mediated NPC inva-
sion and metastasis, we used a stable isotope labeling
with amino acids in cell culture (SILAC) to further analyze
the proteomic changes caused by DNP. We found that 371
proteins were regulated by DNP, most of which were not
previously reported to be involved in NPC metastasis. Ana-
lysis of this vast information provides us with better under-
standing of the complex regulatory mechanism of NPC
high metastasis. Using bioinformatics analysis, we detected
many novel signaling components in DNP-regulated sig-
naling pathways.
Methods
Cell culture and stable isotope labeling
NPC cell line 6-10B was derived from the cell line
SUNE-1, and has a low metastatic ability [19]. Thus,
6-10B cells were used in the present study to investigate
DNP-mediated NPC metastasis. DNP was a carcinogens
specially for NPC and its chemical structure is shown








or conventional L-lysine and L-arginine (“light”) supple-
mented with dialyzed fetal bovine serum. After six cell
doublings, we assessed the labeled amino acids in cells,
and then identified whether cells were completely incor-
porated by matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry using an Autoflex
MALDI-TOF-MS instrument (Bruker Dalton). Mass
spectra were searched against a database of human pro-




To determine the non-cytotoxic concentration of DNP,
3-(4,5-dimethylthiazol-2-yl)-5-(3- carboxyme -thoxyphe-
nyl)- 2-(4-ulfophenyl) -2H-tetrazolium (MTT) assay was
performed to determine the viability of “heavy” labeled6-10B cells. Briefly, “heavy” labeled 6-10B cells were seeded
in 96-well plates at a density of 5 × 103 cells / well and trea-
ted with DNP at a concentration between 0 and 18 μM
at 37°C for 24 h. Thereafter, 20 μl MTT (5 mg/ml, 0.5%
MTT) was added per well for 4 h. The viable cell number
per dish is directly proportional to formazan production,
which can be measured spectrophotometrically at 492 nm
following solubilization with isopropanol.Lactate dehydrogenase assay
To further evaluate the non-cytotoxic concentration of
DNP in “heavy” labeled 6-10B cells, lactate dehydrogenase
(LDH) activity in cell culture media was detected after
DNP treatment. Briefly, “heavy” labeled 6-10B cells were
seeded in 6-well plates at a density of 2 × 104 cells/well
and treated with DNP at a concentration between 0 and
18 μM at 37°C for 24 h. After the exposure period, media
were collected for LDH activity measurement using the
LDH assay kit (Autec Diagnostica).DNP treatment and protein preparation
DNP crystals were dissolved in DMSO. Appropriate
amounts of the DNP stock solution were added into the
culture medium to achieve the indicated concentrations
(DMSO concentration, 0.1%) and then incubated with
cells for the indicated time periods. At approximately
60% confluence, the “heavy” labeled 6-10B cells were
treated with 10 μM DNP for 24 h according to MTT
assay data, while the “light” labeled 6-10B cells were
treated with only 0.1% DMSO, served as the control.
The treated cells were then harvested and suspended
with lysis buffer. Lysate was centrifuged at 13,200 rpm at
4°C for 30 min. Supernatant fractions were collected and
protein concentrations were determined using BCA
assay kit (Pierce).
Cell invasion and motility assay
Cell invasion and motility were assayed according to
methods described previously with minor modifications
[18]. For the invasion assay, “heavy” labeled 6-10B cells
were treated with the indicated concentrations of DNP
for the indicated times. The treated cells were seeded
into Boyden chamber with Matrigel (Neuro Probe,
Cabin John, MD) at the upper part at a density of 1.5
× 104 cells/well in 50 μl serum-free medium and incu-
bated for 12 h at 37°C. The bottom chamber also con-
tained standard medium with 20% fetal bovine serum.
The cells invaded to the lower surface of chamber
membrane were fixed with methanol and stained with
hematoxylin and eosin. The invaded cell numbers were
counted under a light microscope. The motility assay
was performed as described in the invasion assay with-
out Matrigel coating.
Figure 1 Non-cytotoxic concentration of DNP in stable isotope-
labeled 6-10B cells. A, Structure of DNP, an N-nitroso compound.
B, Stable isotope-labeled 6-10B cells were treated with the indicated
DNP concentration and then subjected to MTT cell viability assay as
described in the Materials and Methods. “OD” indicates the relative
optical density at 492 nm. C, After stable isotope-labeled 6-10B cells
were treated with the indicated DNP concentration, and cell media
were subjected to the LDH assay. LDH activity is per 1 L of media.
Data are presented as the means ± standard deviation from three
independent experiments, statistically analyzed using Student’s
t- test (*, p < 0.05; α=0.05).
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in nude mice
Nude mice experiments were performed as previously
described [18]. Twenty BABL/c nude mice (approxi-
mately 5–6 weeks old) were purchased from the Animal
Center of Central South University. All animal studies
were conducted according to the standards established
by the Guidelines for the Care and Use of Laboratory by
Animals of Central South University. Additionally, the
present study protocols were approved by the ethical
committee at Central South University. Briefly, 100-μl
aliquots of 6-10B cell suspensions (1 × 104 cells) were
mixed with Matrigel and injected respectively into the
tail veins of the 20 nude mice. They were then randomly
divided into two groups, DNP-treated and control
groups, containing 10 mice per group. The DNP-treated
group was abdominally injected with DNP at a dose of
40 mg/kg (body weight) twice a week for 60 days using a
1-ml sterile syringe. The control group was treated with
0.1% DMSO. After DNP treatment, the metastasis of
6-10B cells to the lung, liver, and lymph nodes was
observed. Their metastatic abilities were evaluated by
counting tumor metastatic foci on day 60 after the
injection.
Gel electrophoresis and in-gel trypsin digestion
Prior to gel electrophoresis, equal amounts of DNP-
treated and untreated cell proteins were mixed, separated
using 10% SDS-PAGE (4 – 12% Bis-Tris Novex minigel,
Invitrogen), and stained silver solution to visualize the
gel bands. The entire protein gel lanes were horizontally
excised and cut into 48 slices each, and then destained,
reduced, alkylated and digested with gold-trypsin at
37°C overnight as described previously [20]. The result-
ing tryptic peptides were extracted by 90% acetonitrile
(Fisher) and 2.5% trifluoroacetic acid (Promega), lyophi-
lized in a SpeedVac, and dissolved in 1% formic acid and
2% acetonitrile before liquid chromatography-tandem
mass spectrometry (LC-MS/MS) analysis.
LC-MS/MS analysis
The peptide mixtures were separated using Finnigan
Surveyor high-performance liquid chromatography system
(Thermo Electron, San Jose, CA) on a C18 reverse phase
column, which was coupled online to a linear ion trap/
Orbitrap (LTQ-Orbitrap) mass spectrometer (Thermo
Electron, San Jose, CA). Briefly, the peptide mixtures
were first loaded onto a C18-reversed phase column
(100-μm inner diameter, 10-cm long, 3-μm resin from
Michrom Bioresources, Auburn, CA), and then sepa-
rated at a maximal flow rate of 300 nl/min controlled by
IntelliFlow technology. The peptide mixtures were sepa-
rated using the following parameters: 1) mobile phase A:
0.1% formic acid, 2% the acetonitrile, Dissolved in water;
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nitrile; 3) flow rate: 300nl/min; 4) gradient: B-phase
increased from 5% to 35%, 120min. Next, the eluate was
online analyzed online in LTQ-Orbitrap mass spec-
trometer operated in a data-dependent mode, the
temperature of the heated capillary was set to 200°C,
and the spray voltage was set to 1.85 kV. Full-scan
MS survey spectra (m/z 400–2,000) in the profile
mode were acquired in Orbitrap with a resolution of
60,000 at m/z 400 after the accumulation of 1,000,000
ions, and followed by five MS/MS scans in LTQ with
the following Dynamic Exclusion settings: a repeat
count of 2, a repeat duration of 30 s, and an exclusion
duration of 90 s. The lock mass option was enabled
for survey scans to improve mass accuracy [21]. The
data were acquired using Xcalibur (Thermo Electron,
version 2.0.7).
Protein identification, quantification and bioinformatics
analysis
Protein identification and quantification were performed
as previously described with minor modifications [22,23].
Briefly, the mass spectrometric raw data were analyzed
using MaxQuant 1.0.13.13 software and the derived peak
lists were searched using the Mascot search engine
(Matrix Science, version 2.2.04, London, UK) against a
concatenated real and false International Protein Index
human protein database (V3.52). Mascot search results
were further processed by MaxQuant 1.0.13.13 at the
false discovery rate of 1% at both the protein, peptide,
and site levels. The normalized heavy versus light (H/L)
ratios, significance, and variability (%) were automatically
produced by MaxQuant 1.0.13.13 software. The final
reported protein ratio represents a normalized ratio of
H/L SILAC obtained in all technological repeats where
the same protein was identified. International Protein
Index numbers of all significantly regulated proteins
and some unaltered proteins were imported into the In-
genuity Pathway Analysis software tool (www.ingenuity.
com) for bioinformatics analysis based on published
reports and databases such as Gene Ontology, Uniport,
and TrEMBL.
Western blotting analysis
Western blotting was used to validate the expression
levels of eight dysregulated proteins in DNP-treated and
untreated 6-10B cells as described above. 6-10B cells
were treated with 5, 10, 20 μM for dose-course and trea-
ted with 10 μM for 6, 12, 18, 24, 36, 48 h for time-
course. After treatment, supernatants were centrifuged
at 300 × g for 4 min and 2000 × g for 8 min to remove
dead cells and cell fragments, and proteins were concen-
trated by centrifugal ultrafiltration using Microcon YM-3
Centrifugal filters (Millipore, Billerica, MA, USA). Thetreated cells were disrupted with 0.6 ml lysis buffer
[1 × PBS, 1% Nonidet P-40, 0.1% SDS, and freshly added
100 μg/ml PMSF, 10 μg/ml aprotinin, 1 mM sodium
orthovanadate]. Cell lysates were then subjected to cen-
trifugation of 10000 × g for 10 min at 4°C. Equal protein
amounts of cell lysates and culture supernatants were
separated by 10% polyacrylamide gel electrophoresis,
and transferred onto nitrocellulose membranes (Bio-rad).
The membranes were subsequently incubated with 5%
non-fat milk in Tris-buffered saline containing 0.05%
Tween-20 for 1 h to block non-specific binding and then
overnight with antibodies against aldo-keto reductase
(AKR) 1B10, S100P, cathepsin B, cathepsin D, ferritin,
α-E-catenin (Cell Signaling Technologies), or clusterin,
AGR2, and GAPDH (Santa Cruz.), then incubated with
the secondary antibody for 1 h at room temperature. The
band signal was developed using 4-chloro −1-napthol/
3,3-o-diaminobenzidine, and relative photographic density
was quantitated using a gel documentation and analysis
system (Pierce, Rockford, USA).
Gene transfect and wound-healing assays
Wound-healing assay was performed as previously
described with minor modifications [24]. 6-10B cells
(2 × 106) were seeded in 10-mm plates at 37°C for 24 h,
and transiently transfected with si-AGR2 or si-mock
(Dharmacon) [25] using Lipofectamine 2000 reagent (Life
Technologies, Inc.) following the manufacturer’s suggested
protocol, and then confluent monolayer of the transfected
cell was wounded using a plastic tip. Cells were treated
with DNP at 10 μM, and then photographed after 48 h.
The cells moving cross the boundaries lines were counted.
The transfect cell samples were harvested, and total
proteins were extracted. These protein samples were sub-
jected to Western blotting analysis.
Results and discussion
In this study, quantitative proteomics with SILAC were
used to identify the different protein of 6-10B cells with or
without DNP treatment. As the first step 6-10B cells were
labeled with amino acid, and then we assessed the incorp-
oration efficiency of 2H4-L-lysine and
13C6
15N4-L-arginine
in 6-10B cells for full incorporation in all proteins after six
cell doublings. Three peptides, VEVTEFEDIK (Figure 1A),
GHYTEGAELVDSVLDVVR (Figure 1B) and LRQPFFQK
(Figure 1C) were separated by 4 Da, 10 Da, and 14 Da cor-
responding to the mass difference between the above light
and heavy isotopes. The entire signal corresponded to the
heavy peptide, indicating that incorporation of 2H4-L-lysine
or 13C6
15N4-L-arginine was complete. To illustrate the
quality of the protein identifications reported, we present
MS and MS/MS spectra of clusterin and AKR1B10 from
the data obtained from the LTQ-Orbitrap mass spectrom-
eter (Figure 1D, E).
Figure 2 Labeling of 6-10B cells with 2H4-L-lysine and
13C6
15N4-L-arginine. 6-10B cells were cultured in DMEM containing
2H4-L-lysine and
13C6
15N4-L-arginine or conventional L-lysine and L-arginine as described in the Materials and Methods. A, the peptide VEVTEFEDIK has a charge
state of 1+ and contains one lysine; B, the peptide GHYTEGAELVDSVLDVVR has a charge state of 1+ and contains one arginine. C, the peptide
LRQPFFQK has a charge state of 1+ and contains one lysine and one arginine. The peaks marked with blue and red represent the light isotope
signal and the heavy isotope signal, respectively. Representative MS/MS and MS spectra from clusterin (D) and AKR1B10 (E). The inset shows the
relative ratio of heavy to light versions of each precursor ion.
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chemical structure is shown in Figure 2A. Although it is
known that the non-cytotoxic concentration of DNP to
6-10B cells is 0–4 μM, even up to 6 μM [18], we deter-
mined the non-cytotoxic concentration of DNP in stable
isotope-labeled 6-10B cells, cell viability was not signifi-
cantly altered at 0–10 μM DNP compared with control
cells (0.1% DMSO; Figure 2B, *, p < 0.05). To further
confirm that 0–10 μM DNP was non-cytotoxic, LDH ac-
tivity in the cell culture media was detected after DNP
treatment. The data revealed that LDH activity was not
significantly altered by treatment with DNP concentra-
tions between 0 and 10 μM (Figure 2C, *, p < 0.05). Thus,
in all subsequent experiments, the concentration of
10 μM DNP was used.
Although previous work has shown that DNP is
involved in NPC metastasis, we first confirmed here
that DNP mediated NPC metastasis. A Matrigel-coatedBoyden chamber was used to measure invasion. 6-10B
cells were treated with DNP at 0, 2, 4, 6, 8, and 10 μM
for 24 h and then seeded into the Boyden chamber.
The cells that invaded the lower chamber were counted.
The invaded cells increased dose-dependently after DNP
treatment (Figure 3A-c, lanes 4 to 6 vs lane 1; *, p < 0.05).
Compared with the control, the increase was 4.1-fold with
8 μM DNP (Figure 3A-c, lane 5). For detecting 6-10B cell
motility with DNP treatment, the treated cells were seeded
into a Boyden Chamber uncoated with Matrigel, and
motile cells were counted. A similar effect was observed
for the motility of DNP-treated cells (Figure 3B-c, lanes 4
to 6 vs lane 1; *, p < 0.05). The cell motility increased by
5.6-fold after treatment with 8 μM DNP (Figure 3B-c,
lane 5). To further confirm DNP –involved metastasis
in vivo, the treated 6-10B cells were mixed with Matrigel,
and then were injected into the tail veins of BABL/c
mice. Tumor metastatic nodes of 6-10B cells in the
Figure 3 DNP-mediated 6-10B cell invasion and motility in vitro or metastasis in vivo. A, stable isotope-labeled 6-10B cells were treated
with the indicated DNP concentration for 24 h. The treated cells were subjected to analyses for motility and invasion as described in the Materials
and Methods. A, invasion of 6-10B cells at various concentrations. Arrow, invaded cell. B, motility of 6-10B cells at various concentrations; Arrow,
motile cell. The data were statistically analyzed by one-way analysis of variance with post hoc Dunnett’s test (*, p < 0.05). Scale bar, 5 μM.
C, twenty nude mice were injected with 6-10B cells in Matrigel through the tail vein (1 × 104 cells/mouse), and then randomly divided into two
groups with 10 mice per group. The DNP group was abdominally injected with DNP using a stumped needle at a dosage of 40 mg/kg
(bodyweight), twice a week for 60 days. The control was injected with 0.1% DMSO. After 60 days, tumor metastatic foci of 6-10B cells were
observed. Scale bar, 10 μM. Arrow, tumor metastatic foci.
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foci in mice lungs were significantly observed in nude the
mice with DNP treatment (Figure 3C, left panel vs right
upper line), and pathologically confirmed under micro-
scope (Figure 3C, left panel vs right down line). These
data indicated that DNP mediates NPC metastasis in
vitro and in vivo.
To fully investigate the mechanism of DNP-mediated
NPC metastasis, SILAC coupled with LC-MS/MS was
used to identify and quantify the proteomic differences.
A total 2853 proteins were detected, and 2698 (94.57%)
proteins could be quantified. Of these 2698 protein, 172
were calculated to be highly up-regulated, and 199 were
significantly down-regulated at a ratio H/L >2.0 or ratioH/L <0.5 and p < 0.05 (Figure 4A). To gain functional
insight into the cellular proteome, the 172 up-regulated
and 199 down-regulated proteins were respectively
assigned to different molecular functional classes and
subcellular annotations according to the underlying bio-
logical evidence from the Gene Ontology database
(false discovery rate < 0.05). Because some proteins
generally have more than one component annotation
or function annotation, the sum of each category may
be higher than 100%. The 15 most abundant terms
are shown in Figure 4B, C, with additional data shown
in Additional file 1: Table S1. Mitochondrion proteins
and proteins related to junctional mechanisms were
highlighted in up-regulated and down-regulated
Figure 4 Proteome quantitation, significance, and classification analysis. A, signal intensities of all quantified proteins after DNP treatment
are shown as a function of their fold change. Ratios of most proteins distributed around 1.0 (Log10 (ratio) = 0), indicating that whole proteins of
the two groups of cells were mixed equally and 6-10B cells were fully labeled. The spread of the cloud was lower at high abundance, indicating
that quantification is more precise, and their fold change level is indicated in blue, red, and green, respectively. To reduce test error, proteins at
more than 2.0-fold or less than 0.5-fold and p < 0.05 were deemed to indicate significantly changed proteins induced by DNP treatment.
Together, this gives quantifiable results for 371 proteins being significantly altered upon DNP, with 172 and 199 proteins being up- and down-
regulated, respectively. The 15 most abundant terms of component (B) and function annotation in disregulated proteins (C) are shown. As each
protein is generally assigned to more than one term, the percentage of proteins in each term is shown instead of the total number to avoid
redundancy. Number distribution of the 15 most abundant terms for up-regulated or down-regulated proteins (D). Oxidoreductase activity-1, 2, 3,
and 4 represent respectively oxidoreductase activity, oxidoreductase activity acting on NADH or NADPH, oxidoreductase activity acting on the
CH-CH group of donors, and oxidoreductase activity acting on the CH-CH group of donors, NAD or NADP as acceptor (E).
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ther exploration at subcellular levels is necessary.
Functional analysis of these differential proteins
showed that DNP-treated high metastatic 6-10B cells
demonstrated significant changes in oxidoreductase
activity, cofactor binding, and cytoskeletal protein
binding (Figure 4E).
Proteins that changed significantly in DNP-treated cells
were mapped to 15 specific functional networks with
each network containing 11 or more “focus” members
(Figure 5A, Additional file 2: Table S2). The four net-
works of interest correspond to the following: (A) Cancer,Renal and Urological Disease, Cell Death (Figure 5B);
(B) Cancer, Reproductive System Disease, Cell Death
(Figure 5C); (C) Cellular Movement, Lipid Metabolism,
Molecular Transport (Figure 5D), and (D) Protein Syn-
thesis, Cell Death, Cellular Growth and Proliferation
(Figure 5E). Proteins that are present in these pathways
and that were identified in our analysis as up-regulated are
depicted in red, and proteins that were identified as down-
regulated are shown in green. Proteins known to be in
the network but that were not identified in our study are
depicted in white. The shade of the color indicates the
magnitude of the change in protein expression level.
Figure 5 (See legend on next page.)
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Figure 5 Ingenuity Pathway Analysis of proteins induced by DNP. A, overview of 15 specific functional networks, each of which contains 11
or more “focus” proteins (proteins that were significantly up- or down-regulated). Each box contains an arbitrary network number. B, cancer, renal
and urological disease, and cell death. C, cancer, reproductive system disease, and cell death. D, cellular movement, lipid metabolism, and
molecular transport. E, protein synthesis, cell death, and cellular growth and proliferation. Red, up-regulated proteins; Green, significantly down-
regulated proteins; White, proteins known to be in the network but were not identified in our study. The color depth indicates the magnitude of
the change in the protein expression level. Lines connecting the molecules indicate molecular relationships. Dashed lines indicate indirect
interactions, and solid lines indicate direct interactions. The arrow styles indicate specific molecular relationships and directionality of the
interaction. Abbreviations are shown in Additional file 2: Table S2.
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ferent fold changes, AKR1B10, clusterin, cathepsin B,
cathepsin D, ferritin, α-E-catenin, AGR2, and S100P
were chosen to validate SILAC results. Western blotting
results showed that the ratios of eight representative
proteins between treated and untreated cells showed
either close-degrees or similar fold changes consistent
with those obtained from SILAC (Figure 6A). Quantifica-
tion results by SILAC of the eight proteins are shown in
Additional file 3: Table S3. Some of them are secretory
proteins, to determine whether DNP also induces these
secretory proteins, AKR1B10, cathepsin B and clusterin
in the culture supernatants of DNP treated 6-10B cells
were detected. The results showed that AKR1B10,
cathepsin B and clusterin dramatically increased in the
culture supernatants after DNP treatment (Figure 6B).
These findings imply that DNP may induce 6-10B cells
to secrete AKR1B10, cathepsin B and clusterin.
To further confirm whether the different proteins involve
DNP-mediated NPC metastasis, we chose high-expressed
protein AGR2 as target. DNP induced AGR2 expression atFigure 6 Differential protein expression confirmed using
Western blotting. A, eight representative proteins, aldo-keto
reductase (AKR) 1B10, clusterin, cathepsin B, cathepsin D, ferritin,
α-E-catenin, AGR2, and S100P were detected in 6-10B cells with or
without DNP treatment using Western blotting. GAPDH served as a
loading control. The relative photographic density was quantitated
using a gel documentation and analysis system. B, AKR1B10,
Cathepsin B and Clusterin were detected in the cell culture
supernatant of 6-10B cells with or without DNP treatment using
Western blotting. WB, Western blotting. SILAC, stable isotope
labeling with amino acids in cell culture.dose- and time- course (Figure 7A). As a metastasis-
associated protein, AGR2 may play an important role in
DNP-mediated metastasis. The next step is to observe
DNP-mediated metastasis when AGR2 blocked. We used
si-AGR2 to knockdown AGR2 (Figure 7B), and then used
wound-healing assays to detect the cell motility of
6-10B-siAGR2 with DNP treatment. Following si-AGR2
transfect, DNP-mediated motility decreased, and conse-
quently the cells were unable to migrate into the wound
(Figure 7C, panel b vs. d and Figure 7D, lane 2 vs. 4).
Hence, we concluded that AGR2 plays an important role
in DNP-mediated metastasis.
Conclusion
In clinic, NPC has the features of high invasion and
metastasis, but its mechanism has been unclear. As
one of three carcinogen factors for NPC, the Epstein–
Barr virus (EBV) has been proven to be involved in NPC
metastasis through latent membrane protein 2A inducing
epithelial-mesenchymal transition (EMT), however latent
membrane protein is positive at only a 56.7% rate [26].
Recently, another important carcinogen factor, DNP was
also found to be involved in NPC metastasis [18]. In the
present study, using SILAC and a systematic data ana-
lysis method, we obtained unbiased interpretation of
NPC cell metastasis induced by DNP. Approximately
2698 proteins were quantified and 371 of these proteins
showed apparent alterations in expression levels after
DNP treatment, involving the regulation of biosynthesis
and energy metabolism, as well as cell adhesion or inva-
sion. We speculated that biosynthesis, energy metabolism
and invasion are associated with NPC metastasis
mediated by DNP. Based on subcellular and biological
function analysis, many differential proteins in the
present study were located in mitochondrion, such as
mitochondrial membrane part, and mitochondrial re-
spiratory chain. Additionally, tumor cells with mitochon-
dria damage or dysfunction were reported to enhance
anti-apoptosis ability and invasion [27,28]. This suggests
that mitochondrial dysfunction may be linked to metas-
tasis of DNP-treated 6-10B cells.
In the differential proteins mediated by DNP, oxidore-
ductase activity and oxidoreductase activity acting on
NADH or NADPH, the CH-CH group of donors, and
Figure 7 DNP-mediated 6-10B cell motility through AGR2. A, 6-10B cells were treated with the indicated concentration DNP for dose-course,
and treated with 10 μM DNP for the indicated time for time-course. AGR2 expression in the DNP-treated cells was detected using Western-
blotting. 6-10B cells (2 × 106) were transiently transfected with si-AGR2 or si-mock, incubated at 37°C for 16–24 h. Confluent monolayer of the
transfect cells was then wounded using a plastic tip, and then treated with 10 μM DNP. (a) 6-10B cells treated with 0.1% DMSO. (b) 6-10B cells
treated with 10 μM DNP. (c) The transfect with AGR2 si-RNA treated with DMSO. (d) The transfect treated with DNP. B, AGR2 expression in the
above transfect cells with DMSO or DNP treatment using western-blotting. C, The treated cells were observed under microscope, and the cells
migrating cross the boundaries lines in the center of the wells were counted. D, Numbers of cells that moved cross the lines (10 fields). The data
are represented as the mean ± SD from three independent experiments. Results were statistically analyzed using one-way analysis of variance
(ANOVA) with a post hoc Dunnett’s test (* p < 0.05). The error bars represent SDs. Scale bar, 10 μM. Arrow, cells moving cross the boundary.
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acceptor related to proteins accounted for a large pro-
portion. Peroxiredoxins 3, NADH-dehydrogenase ubi-
quinone iron-sulfur protein 3 (NDUFS3), NADH-
dehydrogenase ubiquinone 1 beta subcomplex subunit
8 (NDUFB8), pirin, ferritin heavy chain, and AKR1 were
significantly up-regulated in the high metastatic 6-10Bcells with DNP treatment. Oxidative stress have been
shown to play important roles in tumorigenesis and
progression of tumors [29], in which there is aberrant
or improper regulation of the redox status. The balance
of redox state affects many physiological and patho-
physiological processes of cells, its mechanisms include
gene transcription, cell signal transduction, activity of
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tion, adhesion, and apoptosis. These findings suggest
that the significant change of oxidoreductase activity in
high metastatic 6-10B cells with DNP treatment is cor-
related with the status of oxidative stress and imbalance
of the redox state.
Cytoskeleton has been identified as a major target for
destruction during apoptosis and is important under
pathological conditions such as cancers [30]. The differ-
ential proteins were distributed in the cytoskeleton, in-
cluding N-myc downstream-regulated gene 1 protein,
paxillin, and syntenin-1. Conversely, some proteins asso-
ciated with the cytoskeleton were up-regulated, such as
catenin alpha-1, radixin, macrophage-capping protein,
integrin beta-5, tubulin-specific chaperone D, tubulin
beta 2C (TUBB2C), tubulin beta 2A, and tubulin 5 beta.
And subcellular localization of these differential proteins
is related to junctional mechanisms. Based on these data,
we speculate that in high metastatic 6-10B cells with
DNP treatment, dynamic modifications and remodeling
in the cytoskeleton exist, and the dynamic alteration
affects endocytosis, cell shape, cell motility, cell adhesion
and invasion.
Additionally, some important proteins directly related
to metastasis were discovered in our study, such as,
annexin A6, S100P, S100A4, hot shock protein 90B1,
ferritin heavy chain, TUBB2A, and anterior gradient-2
(AGR2, Additional file 3: Table S3). Cathepsin B,
AKR1B10 and custerin were not only up-regulated in
6-10B cells with DNP treatment, but also in the cell
culture supernatant. Cathepsins, initially described as
intracellular peptide hydrolases, play a role in invasion
and metastasis of cancer [31]. In the present study,
cathepsins B and D were respectively up-regulated
7.9-fold (Additional file 3: Table S3) and 4.6-fold
(Additional file 3: Table S3), respectively. Cathepsin B is a
key enzyme in invasion and metastasis of malignant
tumors. It is up-regulated in laryngeal cancer [32], cer-
vical cancer [33,34], and bladder cancer [35], and its ex-
pression level is correlated with metastatic potential.
Cathepsin D, a lysosomal aspartate proteolytic enzyme
that is similar to cathepsin B, also plays an important
role in invasion and metastasis of cancer. It is up-
regulated in metastasis of some malignant tumors, in-
cluding primary laryngeal cancers correlated with neck
lymph node involvement [36], gastric cancer with lymph-
atic and/or blood vessel invasion [37], and breast cancer.
Furthermore, Cheng et al. [38] found that significant
cathepsin D expression occurred in lymph node metasta-
sis versus primary NPC and was significantly correlated
with advanced clinical stage, recurrence, and lymph node
and distant metastasis. AGR2 was reported to be linked
with several human cancers and induced metastasis
[39]. Additionally, Dumartin, et al. [25] found thatcathepsins B and D are downstream functional mole-
cules of the proinvasive AGR2 in vitro, and AGR2,
cathepsins B and D were considered to be essential for
dissemination of pancreatic cancer cells in vivo. High
expressed-cathepsins B and D in DNP-treated 6-10B may
be mediated by AGR2, but it is also possible that DNP dir-
ectly mediated cathepsins B and D. Additionally, DNP-
induced 6-10B motility decreased when AGR2 blocked
(Figure 7). We speculated that cathepsins B, D and AGR2
expression mediated by DNP and AGR2 regulating cathe-
psins B, D are involved in NPC metastasis.
Significantly, AKR1 proteins were predominantly
up-regulated in high metastatic DNP-treated 6-10B cells,
including AKR1C1, AKR1B10, AKR1C3, and AKR1B1
(Additional file 3: Table S3). Family members of AKR1C
play a pivotal role in maintaining steroid homeostasis
and catalyzing reductive detoxification of reactive alde-
hydes and ketones, which are produced as a result of
oxidative stress [40,41]. AKR1B10 is also correlated posi-
tively with tumor size and lymph node metastasis [42].
These findings suggest that DNP would affect oxidative
stress and steroid homeostasis in 6-10B cells through
the above aldo-keto reductase family 1 proteins, thereby
increasing 6-10B cell metastasis.
Higher clusterin levels were expressed in various malig-
nant tumors with metastasis including ovarian [43], breast
[44], and gastric cancers [45]. An emerging query, cluster-
ins enhanced cell invasion and metastasis of tumors
through EMT. Lee, et al. [46] found that clusterin was
involved in Smad2/3 stability at the protein level, and
believed that clusterin regulates transforming growth
factor-beta signaling pathway by modulating the stability of
Smad2/3 proteins and mediates EMT. Lenferink et al. [47]
also found that clusterin gene expression was highly up-
regulated throughout transforming growth factor-beta, and
speculated that secreted clusterin served as an important
extracellular promoter of EMT. In the present study, pro-
teins related to EMT and cell adhesion were also dysregu-
lated, including clusterin myosin-VI, catenin alpha-1
(CTNNA1), fibronectin type III domain-containing protein
3B (FNDC3B, 2.1-fold), L1 cell adhesion molecule
(L1CAM), desmoplakin, plakophilin-3 (Additional file 3:
Table 3), implying that the mobility of DNP-induced 6-10B
cells is probably related to EMTand cell adhesion.
The SILAC technique was used to conduct a comparison
of the proteomes of 6-10B cell metastasis induced by DNP.
A cooperative response, including many proteins, and a
group of pathways were identified and some interesting
clues were provided. DNP may induce a change in abun-
dance of mitochondrial proteins, mediate the status of oxi-
dative stress and the imbalance of the redox state, and
increase cytoskeletal protein, cathepsin, AGR2, and clus-
terin expression, and finally promote cell metastasis. DNP
may be involved in NPC metastasis through regulation of
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ism, molecular transport, cell death, and cellular growth
and proliferation signaling pathways. DNP may also induce
6-10B cells to secrete AKR1B10, cathepsin B and clusterin.
These dataset provide important clues for investigation on
high metastatic NPC.
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